Company / SG&A Expense
PRECIGEN, INC. SG&A Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$70.1M
FY2025
5-year range
$70.1M / $70.1M
FY2021-FY2025
Trend
-
vs FY2024
Sector context
#133 of 213
Health Care
What the data says
At $70M, PRECIGEN, INC.'s sg&a expense ranks #81 of 213 in the Health Care sector. Improved from $146M to $70M over the past 8 years.
Based on SEC 10-K filings.
$70M in FY2025.
Improved from $146M to $70M over the past 8 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#81 of 213 in Health CareTop 38% of 213This company $70.1M Sector average $722.3M
▼
-90.3% below sector average
Key checks
Key Insights
- Ranks #133 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -14.47 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $70.1M | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | $137.8M | -5.7% |
| FY2017 | $146.1M | +2.7% |
| FY2016 | $142.3M | +323.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026